Global Kidney-on-a-chip Market Growth (Status and Outlook) 2024-2030

Global Kidney-on-a-chip Market Growth (Status and Outlook) 2024-2030

According to this study, the global Kidney-on-a-chip market size will reach US$ million by 2030.

Scientists have used a "kidney on a chip" device to mimic the flow of medication through human kidneys, a technique that may lead to more precise dosing of drugs, including some toxic medicines used in ICU. Precise dosing in intensive care units (ICU) is critical, as up to two-thirds of patients in the ICU experience serious kidney injury.

Renal cells and nephrons have already been simulated by microfluidic devices. "Such cell cultures can lead to new insights into cell and organ function and be used for drug screening". A kidney-on-a-chip device has the potential to accelerate research encompassing artificial replacement for lost kidney function. Nowadays, dialysis requires patients to go to a clinic up to three times per week. A more transportable and accessible form of treatment would not only increase the patient’s overall health (by increasing frequency of treatment), but the whole process would become more efficient and tolerable. Artificial kidney research is striving to bring transportability, wearability and perhaps implantation capability to the devices through innovative disciplines: microfluidics, miniaturization and nanotechnology.

This report presents a comprehensive overview, market shares, and growth opportunities of Kidney-on-a-chip market by product type, application, key players and key regions and countries.

Segmentation by product type:
Child Kidney-on-a-chip
Adult Kidney-on-a-chip

Segmentation by Application:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.

Please note: The report will take approximately 2 business days to prepare and deliver.